Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Valeant Pharmaceuticals International Inc. (T.BHC) had Return on Equity of 87.07% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
204.73M |
|
-- |
|
-- |
|
-- |
|
614.19M |
|
-- |
|
193.66M |
|
193.66M |
|
177.06M |
|
177.06M |
|
177.06M |
|
177.06M |
|
614.19M |
|
1.08B |
|
370.90M |
|
373.10M |
|
0.55 |
|
0.55 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
37.72B |
|
-- |
|
-- |
|
-- |
|
37.51B |
|
203.35M |
|
-22.41B |
|
203.35M |
|
369.75M |
|
| Cash Flow Statement Financials | |
691.65M |
|
-318.16M |
|
293.26M |
|
1.66B |
|
2.41B |
|
749.75M |
|
123.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.31 |
|
-- |
|
-- |
|
0.99 |
|
147.88 |
|
69.80% |
|
17.55% |
|
17.55% |
|
-- |
|
5.53% |
|
5.85% |
|
395.62M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.46 |
|
1.14 |
|
78.62 |
|
|
Return on Equity |
87.07% |
-0.79% |
|
0.47% |
|
0.61% |
|
0.55 |
|
1.06 |
|
1.85 |
|